COLO-B Coloplast A/S

Partial data

CPH · DK · Healthcare · Medical Instruments & Supplies · coloplast.com

432.00DKK-0.87%Mkt Cap: 14.31B $P/E: 35.5845d ago

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Co…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc. - Common Stock

$140.43BUSDP/E 44.8

EssilorLuxottica Société anonyme

$72.05BUSDP/E 27.0

BDX

Becton, Dickinson and Company Common Stock

$48.16BUSDP/E 30.5

MDLN

Medline Inc. - Class A common stock

$47.91BUSDP/E 44.5

RMD

ResMed Inc. Common Stock

Alcon Inc. Ordinary Shares

$30.82BUSDP/E 48.7

WST

West Pharmaceutical Services, Inc. Common Stock

$25.69BUSDP/E 46.8

DIM

Sartorius Stedim Biotech S.A.

$22.21BUSDP/E 69.8

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.16BUSDP/E 71.4

SOLV

Solventum Corporation Common Stock

$14.95BUSDP/E 10.7

BAX

Baxter International Inc. Common Stock

$12.14BUSD

COO

The Cooper Companies, Inc. - Common Stock

$10.82BUSDP/E 19.6

AVTR

Avantor, Inc. Common Stock

$10.38BUSD

COO

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

RGEN

Repligen Corporation - Common Stock

$10.25BUSDP/E 248.9

ALGN

Align Technology, Inc. - Common Stock

$10.21BUSDP/E 25.0

ATR

AptarGroup, Inc. Common Stock

$7.62BUSDP/E 21.6

Key Statistics

Company

Market Cap14.31B USD

Enterprise Value17.73B USD

Revenue (TTM)4.14B USD

Gross Profit2.66B USD

Net Income (TTM)735.83M USD

Revenue/Share126.27 DKK

Last Price432.00 DKK

Fiscal Year EndSep 2025

MR QuarterJun 2026

Employees17.2K

CountryDK

SectorHealthcare

IndustryMedical Instruments & Supplies

ISINUS19624Y2000

Valuation

P/E (Trailing)35.58

P/E (Forward)16.87

PEG1.13

EV/EBITDA10.47

EV/Revenue4.28

P/S3.48

P/B7.39

EPS (TTM)12.25

EPS (Forward)26.00

52W Range

369.7022% of range646.60

52W High646.60 DKK

52W Low369.70 DKK

Profitability

Gross Margin67.59%

Oper. Margin26.23%

EBITDA Margin40.87%

Profit Margin18.69%

ROE28.16%

ROA10.51%

Growth

Revenue Growth5.70%

Earnings Growth81.80%

Cash Flow & Leverage

Operating CF402.87M USD

CapEx (TTM)196.05M USD

FCF Margin26.96%

FCF Yield7.81%

Net Debt3.35B USD

Net Debt/EBITDA1.98

Balance Sheet

Debt/Equity1.26

Current Ratio1.56

Quick Ratio0.88

Book Value/Sh59.37 DKK

Cash/Share3.63 DKK

Dividends

Fwd Div Rate23.00 DKK

Trail. Div Rate23.00 DKK

Div. Yield5.28%

5Y Avg Yield2.88%

Payout Ratio187.60%

Ex-Div DateMay 18, 2026

Pay Date—

Splits

Last Split5:1

Split DateDec 19, 2012

Analyst Consensus

Rating3.0 (Hold)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)467.10 DKK

Upside (mean)+8.1%

Target Range370.00 DKK – 625.00 DKK

370.00+8.1% to mean625.00

# Analysts21

Ownership

Shares Out.207.37M

Float144.57M

Insiders29.79%

Institutions32.68%

Technical

SMA 50407.97 (+5.9%)

SMA 200467.22 (-7.5%)

Beta0.55

S&P 52W Chg18.16%

Avg Vol (30d)291.36K

Avg Vol (10d)250.57K

Technical Indicators

RSI (14)56.0

MACD7.3638

MACD Signal7.9004

MACD Hist.-0.5366

BB Upper451.74 DKK

BB Middle429.22 DKK

BB Lower406.71 DKK

BB Width10.49%

ATR (14)11.75 DKK

Vol Ratio (20d)0.93x